Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 9NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma 4Breast Neoplasms 4Sarcoma 3Rhabdomyosarcoma 2Ovarian Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Lung Neoplasms 2Inflammatory Breast Neoplasms 2Fallopian Tube Neoplasms 2Carcinoma 2Teratoma 1Sarcoma, Synovial 1Recurrent Uterine Corpus Sarcoma 1Recurrent Uterine Corpus Carcinoma 1Pancreatic Neoplasms 1Neutropenia 1Neurofibrosarcoma 1Malignant mesenchymal tumor 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Follicular 1Liposarcoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Leiomyosarcoma 1Kidney Neoplasms 1Hodgkin Disease 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Fibrosarcoma 1Esophageal Squamous Cell Carcinoma 1

Interventions

Cytarabine 52Methotrexate 33Cyclophosphamide 33Daunorubicin 29Gene Expression Profiling 27Flow Cytometry 23Vincristine 22Mercaptopurine 19Dexamethasone 19Asparaginase 19Filgrastim 18Microarray Analysis 16Etoposide 16Radiotherapy 15Thioguanine 14Prednisone 14Leucovorin 14Idarubicin 13Polymerase Chain Reaction 12Peripheral Blood Stem Cell Transplantation 12Gemtuzumab 12Doxorubicin 12pegaspargase 10Hydrocortisone 10Calcium Dobesilate 10Busulfan 10Reverse Transcriptase Polymerase Chain Reaction 9Mitoxantrone 9Granulocyte Colony-Stimulating Factor 9Cytogenetic Analysis 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Leukemia × pegfilgrastim × Clear all
NCT00812669 2025-07-08

CLL-Irl Study. CTRIAL-IE (ICORG) 07-01, V7

Cancer Trials Ireland

Phase 2 Completed
52 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡